Back
Intra-Cellular Therapies Stock Predictions
Free Stock Analysis Report: See The True Value of Any Stock
Analyze Any Stock Free
Sell
42
ITCI
Intra-Cellular Therapies
Last Price:
$94.86
Seasonality Move:
2.9%
7 Day Trial
ALL ACCESS PASS
$
7
Unlock the power of "two-minute trades"
Learn how today!Intra-Cellular Therapies Stock Forecast
-
Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 31.2% based on the past 10 years of stock performance.
-
Intra-Cellular Therapies has risen higher in 8 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
-
Is Intra-Cellular Therapies Stock Undervalued?The current Intra-Cellular Therapies [ITCI] share price is $94.87. The Score for ITCI is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
ITCI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Intra-Cellular Therapies Stock Go Up Next Year?
-
Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 31.2% based on the past 10 years of stock performance.
Intra-Cellular Therapies Stock Rating
Sell
42
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies overpriced?
-
Intra-Cellular Therapies has risen higher in 8 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
Intra-Cellular Therapies Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
intracellulartherapies.com
52-Week Data
52-Week High:
98.40
52-Week Low:
62.78
Prediction Charts
Market Cap:
10.1B
Price in USD:
94.87
Volume:
4.1M
Beta:
1.04
Technical Analysis
SMA50:
85.48
SMA100:
80.00
SMA200:
75.72
52-Wk Change:
40.38%
Stock Predictions
-
Is Intra-Cellular Therapies stock public?Yes, Intra-Cellular Therapies is a publicly traded company.
-
What is the Intra-Cellular Therapies stock quote today?The Intra-Cellular Therapies stock price is 94.87 USD today.
-
How to buy Intra-Cellular Therapies stock online?You can buy Intra-Cellular Therapies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-19 | 86.59 | 84.14 | 87.95 | 83.42 |
| Dec-20 | 84.54 | 83.49 | 85.03 | 82.76 |
| Dec-23 | 83.86 | 84.00 | 84.52 | 83.06 |
| Dec-24 | 83.93 | 85.24 | 85.78 | 83.46 |
| Dec-26 | 84.60 | 86.00 | 86.36 | 84.41 |
| Dec-27 | 85.62 | 84.85 | 86.26 | 84.14 |
| Dec-30 | 84.21 | 83.48 | 84.86 | 82.32 |
| Dec-31 | 83.67 | 83.52 | 84.70 | 83.05 |
| Jan-2 | 84.16 | 84.24 | 84.99 | 83.75 |
| Jan-3 | 84.59 | 83.72 | 84.64 | 82.76 |
| Jan-6 | 83.71 | 81.78 | 83.76 | 81.40 |
| Jan-7 | 81.68 | 83.23 | 84.19 | 80.83 |
| Jan-8 | 83.00 | 82.56 | 83.05 | 81.86 |
| Jan-10 | 86.53 | 94.87 | 98.40 | 86.25 |
Intra-Cellular Therapies Earnings
Intra-Cellular Therapies Earnings Report: Per Share Intra-Cellular Therapies Earnings Q1 Q2 Q3 and Q4 last year and next year.
Intra-Cellular Therapies Forecast Revenue Growth
Intra-Cellular Therapies Stock Analysis: Historical quarterly revenues per share for Intra-Cellular Therapies and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.92 per share, and an increase next year of $3.25 per share.
* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.